YARDLEY, Penn. – April 11, 2024 – Herspiegel, a leading provider of world-class commercialization services to life science organizations, is pleased to announce the addition of Kristine Flemister, PharmD, as Principal, Value and Access Communications. With over 25 years of experience in the pharmaceutical industry, Kristine brings a wealth of expertise to Herspiegel’s growing Market Access practice.
In response to the evolving needs of the pharmaceutical industry, Herspiegel has enhanced its Market Access practice to encompass value and access strategy, reimbursement strategy, evidence synthesis and modeling, real world evidence, and now value and access communications. With a focus on creating value and ensuring access for various diseases and increasingly complex therapies, Herspiegel is at the forefront of helping our clients solve their most difficult challenges. Our growth is in direct response to client requests for services, including understanding patient populations and unmet needs, developing evidence-based product differentiation, securing coverage, coding, and payment, as well as product pull-through. Clients value our ability to glean unique insights and create differentiated strategies backed with evidence to deliver optimal levels of access.
According to Jay Jackson, Partner, Market Access, “Kristine’s addition to our expanding practice is an exciting milestone for Herspiegel. Her extensive expertise and client-centric approach perfectly complement our commitment to strategic collaboration. We’re not just advisors; we’re partners, dedicated to helping our clients improve patient access and commercial outcomes.”
Kristine’s extensive experience includes co-founding Xcenda, serving in various roles over more than two decades, including Vice President of Medical Communications, Senior Vice President of Operations, and ultimately President responsible for strategic planning, all business operations, and leadership of a team of more than 700 professionals across North America and Europe. Kristine’s track record and passion for proving and communicating the value of pharmaceuticals will further strengthen Herspiegel’s ability to drive commercial success for its clients.
Kristine Flemister commented, “I am excited to join Herspiegel in an increasingly complex healthcare landscape where ensuring access is more critical than ever. I look forward to leveraging Herspiegel’s range of commercial expertise and resources to deliver innovative solutions that make a meaningful difference for our clients and patients.”
The demand for effective strategies and tactical execution continues to grow as our clients navigate the complex and dynamic network of payers, providers, patient support services, and influencers involved in brand access, reimbursement, and, ultimately, patient utilization. We are excited to continue strengthening our capacity to meet that demand, driven to improve patient access and experience and manufacturers’ commercial outcomes.
About Herspiegel:
Herspiegel provides world-class commercialization services helping biotech start-ups and the world’s largest pharmaceutical companies unlock their brand potential. We are committed to solving critical issues and complex problems through our expertise and insights from medical, market access, marketing and commercial.
